DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production Quotas
Policy
Drug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide public interest in hallucinogenic controlled substances research.”
Trackbacks & Pingbacks
[…] Read more here. […]
[…] may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new drug application submission. And psilocybin is not far […]
[…] may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new drug application submission. And psilocybin is not far […]
[…] may soon feel its impact. MDMA is near the regulatory finish line thanks to MAPS’s recent new drug application submission. And psilocybin is not far […]
Leave a Reply
Want to join the discussion?Feel free to contribute!